Silent Liver Disease Epidemic Sweeps India

Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), a condition formerly identified as Non-Alcoholic Fatty Liver Disease (NAFLD), is increasingly recognized as a significant health challenge, particularly within India. This disease stems from a buildup of excess fat in the liver, often linked to metabolic factors such as obesity, diabetes, and high cholesterol. Its progression can advance from simple steatosis to inflammatory stages, potentially leading to fibrosis, cirrhosis, and even liver cancer.

Given its often asymptomatic nature, proactive screening is essential for those with risk factors. Diagnosis typically involves blood tests and imaging, with tools like FibroScan offering detailed insights into liver health. The management of MASLD hinges significantly on lifestyle modifications. A healthy diet, regular physical activity, adequate sleep, and controlled eating patterns are paramount.

Weight loss, even a modest reduction of 7-10%, can dramatically improve liver fat content. Adopting a diet rich in whole foods and reducing processed items is advised. Regular exercise, incorporating both aerobic and strength training, combats sedentary lifestyles. Addressing sleep disorders and considering intermittent fasting, under medical guidance, are also beneficial strategies. In some cases, pharmacological treatments or bariatric surgery may be considered for severe obesity.

MASLD is a reversible lifestyle disease, not an inevitable health outcome. Awareness of risk factors and consulting a healthcare provider for screening can empower individuals to manage their liver health effectively. The updated terminology emphasizes the critical link between overall metabolic well-being and liver health, serving as a crucial call to action.